TALLAHASSEE, Fla., Feb. 25, 2020 /PRNewswire/ -- According to the Centers for Disease Control and Prevention, suicide is the tenth leading cause of death in the United States and the eighth leading cause of death in Florida.  On Thursday, February 27, advocate

CHANHASSEN, Minn., Feb. 25, 2020 /PRNewswire/ -- On Saturday, March 7, the fifth annual Ri

NASHVILLE, Tenn., Feb. 25, 2020 /PRNewswire/ -- Tivity Health® (Nasdaq: TVTY), a leading provider of nutrition, fitness and social engagement solutions, today announced that its Board of Directors will appoint two new independent directors under an agreement with HG Vora Capital Management, LLC, a Tivity Health shareholder that owns approximately 9.9%

NEW YORK, Feb. 25, 2020 /PRNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) has unveiled the redesign of Fox Trial Finder (michaeljfox.org/trial-finder

BALTIMORE, Feb. 25, 2020 /PRNewswire/ -- Capsulomics, Inc.,  a Baltimore-based molecular diagnostics company whose mission is to detect and prevent cancer through earlier detection, today announced a research partnership with Johns Hopkins University, funded by a 5-year, $3.7 Mi

ENGLEWOOD, Colo., Feb. 25, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain

PRINCETON, N.J., Feb. 25, 2020 /PRNewswire/ -- Bioclinica, a leading provider of clinical science and technology expertise to assist the life science industry, today announced that Charles "Chuck" Bodner has joined the company as Executive Vice President, Chief Operating and Financial Officer. He will assume responsibility for the company's business operations, including

SAN DIEGO, Feb. 25, 2020 /PRNewswire/ -- Mission Healthcare, a San Diego-based home health and hospice provider, and Confirm BioSciences, a leading provider of comprehensive screening tools and solutions, today announced initial engagement data from Mission Healthcare's pilot implementation of HealthState, a proprietary health and we

FOLSOM, Calif., Feb. 25, 2020 /PRNewswire/ -- According to a new epidemiological study, women in their late 50s and early 60s who consumed at least two servings of walnuts

NEW YORK, Feb. 25, 2020 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that Sergio Traversa, Chief Executive Officer of Relmada, will present a corporate overview at the 9th Annual SVB Leerin